Clinical Trial Update: Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing the efficacy and safety of acombination therapy with camrelizumab in second-line neoadjuvant chemotherapy and adjuvant therapy fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer -

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Peking University First Hospital | Conditions: HER2-negative Breast Cancer, Neoadjuvant Therapy | Phase 2 | Status: UNKNOWN